Juluca 50-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FQ96D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,862
Award facts
- Contract value 100% obligated
- $43,862.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $43,862.34 to AmerisourceBergen Drug Corp for the supply of JULUCA 50-25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was executed on November 13, 2025, with an ultimate completion date of November 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, has demonstrated significant capability in meeting federal medical procurement requirements through competitive awards across multiple therapeutic domains. The company maintains an extensive portfolio of federal contracts primarily with DLA and its Medical Supply Chain, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The SPE2DX prime contract facilitates AmerisourceBergen's ability to supply the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with critical pharmaceutical products needed to support military operations and veteran care worldwide.
Quick answers
Who was awarded contract SPE2DR26FQ96D?
SPE2DR26FQ96D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FQ96D worth?
The government has obligated $43,862 on SPE2DR26FQ96D.
Is contract SPE2DR26FQ96D an order under another contract?
Yes. SPE2DR26FQ96D is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FQ96D competed?
The extent of competition for SPE2DR26FQ96D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award